Contribution of insulin deficiency and insulin resistance to the development of type 2 diabetes: nature of early stage diabetes

Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose

(2011) Mustafa Kanat et al.   ACTA DIABETOLOGICA

Decreased beta cell function and insulin sensitivity contributed to increasing fasting glucose in Chinese

(2010) Yan Bi et al.   ACTA DIABETOLOGICA

New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk

(2010) Josée Dupuis et al.   NATURE GENETICS

Insulin Resistance is the Best Predictor of the Metabolic Syndrome in Subjects With a First-Degree Relative With Type 2 Diabetes

(2010) Kristina M. Utzschneider et al.   Obesity

Goals of Treatment for Type 2 Diabetes:  -Cell preservation for glycemic control

(2009) P. Marchetti et al.   DIABETES CARE

One-Year Treatment With Exenatide Improves  -Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients: A randomized, controlled trial

(2009) M. C. Bunck et al.   DIABETES CARE

Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes

(2009) R. A. DeFronzo et al.   DIABETES CARE

The European Exenatide study of long-term exenatide vs. glimepiride for type 2 diabetes: rationale and patient characteristics

(2009) C. Kazda et al.   DIABETES OBESITY & METABOLISM

Prediction of postpartum diabetes in women with gestational diabetes mellitus

(2009) M. Ekelund et al.   DIABETOLOGIA

Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

(2008) D. M. Nathan et al.   DIABETES CARE

Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion

(2008) K. Kirchhoff et al.   DIABETOLOGIA

Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes

(2008) Eleftheria Zeggini et al.   NATURE GENETICS

An overview of pancreatic beta-cell defects in human type 2 diabetes: Implications for treatment

(2007) Piero Marchetti et al.   REGULATORY PEPTIDES